Shenzhen Xinpeng Bio-tech Co., Ltd, established in Xinpeng Bio-tech Garden, 2nd Road Langshan, Hi-tech Industrial North Park, Nanshan District, Shenzhen, Guangdong, on Dec., 18, 1992 and engaged in R & D, production and sales of biotechnological pharmaceutical, owning its own center for R & D and production of biotechnological pharmaceutical and a team of technicians and management personnel with many years? hard work in biotechnological pharmaceutical industry, is one of the biotechnological pharmaceutical manufacturers who passed Chinese GMP certification. At present, two of its products, i.e. G-CSF and EPO, have been distributed/marketed and acquired a leading status in China.
G-CSF, distributed/marketed since 1999.
Generic name: Recombinant Human Granulocyte Colony-stimulating Factor Injection;
Indication: 1. indicated for neutropenia induced by cancer chemotherapy. After cancer patients are treated with marrow-inhibited chemotherapeutic drugs, particularly with strong marrow-deprived chemical drugs, administration of this product is helpful to prevent neutropenia from occurring, to reduce the level of neutropenia, to shorten duration of agranulocytosis, to accelerate recovery of granulocyte, and therefore to reduce danger of infection complicated with fever;
2. to promote increase of neutrophil count after marrow transplantation；
3. indicated for neutropenia induced by myelodysplastic syndrome, for neutropenia induced by aplastic anemia, for congenital and acquired neutropenia, for neutropenia accompanied by myelodysplastic syndrome, and for periodical neutropenia;
Specification: 75μg/0.3ml/vial, 100μg/0.4ml/vial, 125μg/0.5ml/vial, 150μg/0.6ml/vial, 200μg/0.8ml/vial, 300μg/1.2ml/vial;
Storage: store at 2~8 ℃, protect from light and prohibit from freezing;
Shelf period: 24 months;
EPO, distributed/marketed since 2005.
Generic name: Recombinant Human Erythropoietin Injection (CHO Cell);
Indication: indicated for treatment of patients with anemia induced by renal insufficiency, including patients with chronic renal failure, subject to hemodialysis treatment and non-hemodialysis treatment;
Specification: 2,000IU/1.0ml/vial, 3,000IU/1.0ml/vial; 4,000 IU/1.0ml/vial; 10,000 IU/1.0ml/vial;
Storage: store at 2~8 ℃, unsuitable for freezing;
Shelf period: 24 months;
On Nov. 5, 2008, G-CSF and EPO were registered in, and subsequently exported to Pakistan.